Skip to main content

Table 4 Relationships between mutations and MSI patterns by histological subtype

From: Correlation of MLH1 and MGMTexpression and promoter methylation with genomic instability in patients with thyroid carcinoma

MSI status

PTC

FTC

Benign

N (%)

p*

N (%)

p*

N (%)

MSI

59/70 (84%)

0.002

11/12 (92%)

0.012

6/14 (43%)

  MSI-H

38/59 (64%)

 

9/11 (82%)

 

-

  MSI-L

21/59 (46%)

2/11 (18%)

6/6 (100%)

  1. * p values compared against the benign group.